Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting
Older adults have a seven times greater risk than younger adults of being hospitalized due to an adverse drug event.
The objective of this study was to compare the number of potentially inappropriate medications (PIMs) on admission to the number of PIMs on discharge following pharmacist intervention.
Patients and Methods
This was a prospective, single-center pilot study performed at a tertiary medical center. Eighty-two adults aged 65 years or older on five or more medications who were admitted to the general medicine floor between December 2016 and May 2017 were included in the analysis. Pharmacists completed a review of prior admission medications and identified PIMs. Recommendations for PIMs were communicated to the medical team and documented in the patient’s electronic medical record. PIMs were measured by the use of validated screening tools and an assessment of patient-specific parameters.
Fifty-two percent of our patients were taking at least one PIM. The average number of PIMs on admission was found to be 0.84 ± 1.12. Pharmacist intervention resulted in a statistically significant reduction to an average of 0.56 ± 0.91 PIMs (P < 0.01). The mean time to complete the medication therapy management (MTM) process was 49.39 ± 16.2 min per patient.
While pharmacist-driven MTM significantly reduced PIMs in our study, the implementation of this model in the inpatient setting faces several challenges.
The authors of this study would like to thank Kaitlin Crowley and Kevin Charles McLaughlin for their contribution to the medication therapy management process.
Compliance with Ethical Standards
No sources of funding were used to assist in the preparation of this study.
Conflict of interest
Sara Alosaimy, Gretchen Stern, Alka Vaidya, and Kevin Day declare that they have no conflict of interest with the content of the study.
- 8.American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.Google Scholar
- 12.Ensing HT, Stuijt CC, Van den bemt BJ, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.Google Scholar
- 15.Weddle SC, Rowe AS, Jeter JW, Renwick RC, Chamberlin SM, Franks AS. Assessment of clinical pharmacy interventions to reduce outpatient use of high-risk medications in the elderly. J Manag Care Spec Pharm. 2017;23(5):520–4.Google Scholar
- 19.Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother. 2004;2(4):257–64.CrossRefGoogle Scholar
- 21.Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142–8.CrossRefGoogle Scholar
- 24.Draft AGS updated 2018 Beers Criteria® for potentially inappropriate medications in older adults now posted for public comment [news release]. Fulton: American Geriatrics Society. https://www.americangeriatrics.org/sites/default/files/inline-files/2018%20AGS%20Beers%20Criteria%20-%20For%20Review%20Period%208.13.18.pdf. Accessed 13 Aug 2018.
- 34.Ensing HT, Stuijt CC, Van den Bemt BJ, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.Google Scholar